Effect of butorphanol on etomidate-induced myoclonus: a systematic review and meta-analysis

References

• Erdoes G, Basciani RM, Eberle B. Etomidate – A review of robust evidence for its use in various clinical scenarios. Acta Anaesthesiol Scand. 2014;58:380–389. doi:10.1111/aas.1228924588359
   PubMed Web of Science ®Google Scholar
• Desai PM, Kane D, Sarkar MS. Cardioversion: what to choose? Etomidate or propofol. Ann Card Anaesth. 2015;18(3):306–311. doi:10.4103/0971-9784.15979826139733
   PubMedGoogle Scholar
• Doenicke AW, Roizen MF, Kugler J, Kroll H, Foss J, Ostwald P. Reducing myoclonus after etomidate. Anesthesiology. 1999;90:113–119. doi:10.1097/00000542-199901000-000179915320
   PubMed Web of Science ®Google Scholar
• He L, Ding Y, Chen H, et al. Butorphanol pre-treatment prevents myoclonus induced by etomidate: a randomised, double-blind, controlled clinical trial. Swiss Med Wkly. 2014;144:w14042.25317545
   PubMed Web of Science ®Google Scholar
• Voss LJ, Sleigh JW, Barnard JP, Kirsch HE. The howling cortex: seizures and general anesthetic drugs. Anesth Analg. 2008;107(5):1689–1703. doi:10.1213/ane.0b013e318185259518931234
   PubMed Web of Science ®Google Scholar
• Zhu Y, Yang Y, Zhou C, Bao Z. Using dezocine to prevent etomidate-induced myoclonus: a meta-analysis of randomized trials. Drug Des Devel Ther. 2017;11:2163–2170. doi:10.2147/DDDT.S137464
   PubMed Web of Science ®Google Scholar
• Isitemiz I, Uzman S, Toptaş M, et al. Prevention of etomidate-induced myoclonus: which is superior: fentanyl, midazolam, or a combination? A retrospective comparativestudy. Med Sci Monit. 2014;20:262–267. doi:10.12659/MSM.88983324535067
   PubMed Web of Science ®Google Scholar
• Loacker S, Sayyah M, Wittmann W, Herzog H, Schwarzer C. Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa etomidate receptors. Brain. 2007;130(Pt 4):1017–1028. doi:10.1093/brain/awl38417347252
   PubMed Web of Science ®Google Scholar
• Liou JT, Hsu JC, Liu FC, et al. Pretreatment with small-dose ketamine reduces withdrawal movements associated with injection of rocuronium in pediatric patients. Anesth Analg. 2003;97(5):1294–1297.14570640
   PubMed Web of Science ®Google Scholar
• Clark HD, Wells GA, Hut C, et al. Assessing the quality of randomized trials: reliability of the jadad scale. Control Clin Trials. 1999;20:448–452. doi:10.1016/S0197-2456(99)00026-410503804
   PubMedGoogle Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557e560.12958120
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu L, Lyu G. Comparison of the effects of intravenous pre-treatment of butorphanol and dezocine on prevention of etomidate-induced myoclonus. Tianjin Med J. 2015;43(12):1450–1453.
   Google Scholar
• Yan ZY, Guo GJ, Tia NJT. Influence of preinjection butorphanol on myoclonus caused by etomidate during induction of general anesthesia. Med Innovation China. 2015;12(2):32–35.
   Google Scholar
• Zhang J, Liu L, Liu HP, Lv GY. Comparison of butorphanol or midazolam alone and combination of the two drugs in preventing etomidate-induced myoclonus during anesthesia induction. Chin J Anesthesiol. 2015;35(11):1325–1327.
   Google Scholar
• Zhao XH, Li JB, Deng XM, Xiong YC, Zhao JH, Ning JS. Comparison of the effects of intravenous pretreatment with butorphanol and fentanyl on the etomidate-induced myoclonus. Chin J Anesthesiol. 2008;28(3):280–281.
   Google Scholar
• Ren J, Lan P, Yuan RM. Effect of butorphanol on the etomidate-induced myoclonus during general anesthesia induction. Shandong Med J. 2013;48(53):58–60.
   Google Scholar
• Berry JM, Merin RG. Etomidate myoclonus and the open globe. Anesth Analg. 1989;69:256–259.2764296
   PubMed Web of Science ®Google Scholar
• Sedighinejad A, Naderi Nabi B, Haghighi M, et al. Comparison of the effects of low-dose midazolam, magnesium sulfate, remifentanil and low-dose etomidate on prevention of etomidate-induced myoclonus in orthopedic surgeries. Anesthesiology Pain Med. 2016;6(2):e35333. doi:10.5812/aapm.35333
   PubMedGoogle Scholar
• Herrera-Peco I, Wix-Ramos R, Dominguez-Gadea L, et al. Cambios en la perfusión cerebral inducidos por etomidato en pacientes con epi-lepsia del lóbulo temporal. [Changes in cerebral perfusion induced by etomidate in patients with temporal lobe epilepsy]. Rev Neurol. 2009;49(11):561–565.19921619
   PubMed Web of Science ®Google Scholar
• Gancher S, Laxer KD, Krieger W. Activation of epileptogenic activity by etomidate. Anesthesiology. 1984;61:616–618.6497005
   PubMed Web of Science ®Google Scholar
• Kelsaka E, Karakaya D, Sarihasan B, Baris S. Remifentanil pretreatment reduces myoclonus after etomidate. J Clin Anesth. 2006;18(2):83–86. doi:10.1016/j.jclinane.2005.05.00416563323
   PubMed Web of Science ®Google Scholar
• Li X, Liu J, Zhou M, Zhou C. Parecoxib sodium pretreatment reduces myoclonus after etomidate: A prospective, double-blind, randomized clinical trial. Int J Clin Pharmacol Ther. 2017;55(7):601–605. doi:10.5414/CP20276828291508
   PubMed Web of Science ®Google Scholar
• Wang J, Li QB, Wu YY, Wang B-N, Kang J-L, Xu X-W. Efficacy and safty of opioids for the prevention of etomidate-induced myoclonus: a meta-analysis. Am J Ther. 2018;25(5):e517–e523. doi:10.1097/MJT.000000000000040426840341
   PubMed Web of Science ®Google Scholar
• Zou L, Yuan H, Wang HY, Geng Z-Y, Xu L, Sun L. Role of target controlled infusion of remifentanil for the prevention of etomidate induced myoclonus during general anesthesia. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae. 2013;35(1):112–115.23599979
   PubMedGoogle Scholar
• Manocha A, Mediratta PK, Sharma KK. Studies on the anticonvulsant effect of U50488H on maximal electroshock seizure in mice. Pharmacol Biochem Behav. 2003;76(1):111–117. doi:10.1016/S0091-3057(03)00218-113679223
   PubMed Web of Science ®Google Scholar